JP2008180740A - Nuclear power plant constitutive member - Google Patents

Abstract

<P>PROBLEM TO BE SOLVED: To provide a nuclear power plant constitutive member capable of restraining effectively a radionuclide from being deposited. <P>SOLUTION: A ferrite coating film is formed on a surface of a metal member constituting a nuclear power plant at 20-200°C, by bringing a treating liquid prepared by mixing the first chemical containing ferrous (II) ion generated by dissolving metal iron with formic acid, the second chemical (for example, hydrogen peroxide) for oxidizing the ferrous (II) ion to ferric ion (III), and the third chemical (for example, hydrazine) for regulating a pH, containing the ferrous (II) ion and the second chemical, and regulated at 5.5-9.0 of pH, into contact with the surface of the metal member constituting the nuclear power plant. The nuclear power plant constitutive member is thereby obtained with the ferrite coating film formed on its surface. <P>COPYRIGHT: (C)2008,JPO&INPIT

Description

  The present invention relates to a nuclear plant constituent member that suppresses adhesion of radionuclides suitable for application to a nuclear power plant such as a power plant.

In a boiling water nuclear power plant (hereinafter abbreviated as BWR), the coolant is forcedly circulated by a recirculation pump or an internal pump in a nuclear reactor containing a fuel rod in a pressure vessel. The heat generated by the fuel is efficiently transferred to the cooling water. Most of the steam generated in the reactor in this manner is used to drive the steam turbine generator, and the steam discharged from the steam turbine is condensed in the condenser and the steam in the condenser. The condensate condensed in (3) is almost completely degassed and supplied again as reactor cooling water. At that time, oxygen and hydrogen generated by radiolysis of water in the reactor core are almost completely removed in the condenser. Further, the condensate returned to the nuclear reactor is mainly freed of metal impurities by an ion exchange resin filtration device such as a desalinator in order to suppress the generation of radioactive corrosion products in the nuclear reactor.
Heated to near 0 ° C and supplied to the reactor.

In addition, radioactive corrosion products are also generated in the pressure vessel and from water-contact parts such as the recirculation system. Therefore, stainless steel and nickel-based alloys such as nickel base alloys are used as the primary primary components. ing. In addition, the inner surface of stainless steel is built on the reactor pressure vessel made of low alloy steel to prevent the low alloy steel from coming into direct contact with the reactor water. In addition to such material considerations, a portion of the reactor water is purified by a reactor water purification device, and metal impurities generated slightly in the reactor water are positively removed.

However, even if the above-mentioned corrosion countermeasures are taken, the presence of very few metal impurities in the reactor water is inevitable, so some metal impurities adhere to the surface of the fuel rod as metal oxides. The metal element attached to the surface of the fuel rod undergoes a nuclear reaction upon irradiation with neutrons emitted from the fuel, and becomes a radionuclide such as cobalt 60, cobalt 58, chromium 51, manganese 54, and the like.
Most of these radionuclides remain attached to the fuel rod surface in the form of oxides, but some of the radionuclides elute into the cooling water according to the solubility of the incorporated oxides and are called cladding Re-released into the reactor water as an insoluble solid. The radioactive material in the reactor water is removed by the reactor water purification system, but what cannot be removed is accumulated on the surface of the water contact portion of the component while circulating in the recirculation system together with the reactor water. As a result, radiation is radiated from the surface of the component member, which causes radiation exposure of workers during regular inspection work. Although the dose of work exposure is controlled so that it does not exceed the specified value for each person, in recent years, this specified value has been lowered, and it has become necessary to make the exposure dose for each person as low as possible economically. .

Therefore, various methods for reducing the adhesion of radionuclides to the piping and reducing the concentration of radionuclides in the reactor water have been studied. For example, metal ions such as zinc are injected into the reactor water,
By forming a dense oxide film containing zinc on the surface of the recirculation piping that contacts the reactor water,
A method for suppressing the incorporation of radionuclides such as cobalt 60 and cobalt 58 into the oxide film has been proposed (Patent Document 1). In addition, before the radionuclide is dissolved or released in the cooling water, an oxide film is formed in advance on the inner surface of the recirculation system piping and reactor water purification system piping through which the reactor water flows during operation. Has been proposed (Patent Document 2).

JP 58-79196 A JP-A-62-95498

However, as described in Patent Document 1, in the method of injecting metal ions such as zinc into the reactor water, it is necessary to continuously inject zinc ions during operation, and in order to avoid activation of zinc itself. There is a problem that isotope-separated zinc must be used.

Moreover, in the case of the method of forming the oxide film described in Patent Document 2, since the oxide film is formed, for example, in the operating temperature range of BWR (250 to 300 ° C.), there are the following problems. found. That is, according to the study by the present inventors, when the constituent member for generating an oxide film is stainless steel, an inner layer oxide film having a high chromium component is first formed on the surface of the constituent member, and the surface of the inner layer oxide film is formed. It was found that an outer layer oxide film having a small chromium component was formed. In particular, in the case of such an oxide film having a two-layer structure, radioactive Co is added to the inner layer oxide film.
It has been found that -60 and Co-58 are easily taken in, and the adhesion suppression effect of radionuclides is not so great.

An object of the present invention is to effectively suppress adhesion of radionuclides to nuclear plant components.

As a result of various studies in order to solve the above problems, only a dense film of ferrite (for example, magnetite) is obtained under a temperature condition (for example, 100 ° C. or less) at which the diffusion rate of dissolved oxygen into the metal matrix is low. It was clarified that the incorporation of radionuclide cobalt can be suppressed by forming it.

That is, after forming a magnetite film on the stainless steel surface and immersing it in high-temperature water under BWR operating conditions and examining the amount of Co-60 deposited, it was found that the amount of Co deposited can be greatly suppressed as shown in FIG. It was. In FIG. 2, the vertical axis indicates the relative value of the Co-60 adhesion amount of Samples A, B, and C. Sample A is a sample obtained by mechanically polishing the surface of stainless steel, Sample B
Is a sample in which an oxide film was previously formed on the surface of stainless steel under the BWR operating conditions, and Sample C was a sample in which a magnetite film was formed on the surface of the stainless steel at 100 ° C. or less. As is apparent from FIG. 2, the Co of sample C in which a magnetite film was formed as compared with samples A and B.
It can be seen that the amount of adhesion is greatly suppressed. As a method for forming a magnetite film, a technique for forming a ferrite film of a magnetic recording medium (for example, Japanese Patent Publication No. 63-15990).
Issue gazette). However, since the method described in the publication uses chlorine, and chlorine cannot be used from the viewpoint of ensuring the soundness of the components of the nuclear power plant, it is necessary to adopt a method different from the conventional method. .

As a result of intensive studies to solve the above problems, the present inventors adsorb iron (II) ions on the surface of a metal member constituting a nuclear power plant using an organic acid instead of chlorine, and 20 ° C. to 20 ° C.
By oxidizing the adsorbed iron (II) ions at 0 ° C. (preferably 20 ° C. to 100 ° C., more preferably 60 to 100 ° C.), the metal member constituting the nuclear power plant can be used without using chlorine. The inventors have found that a ferrite film capable of suppressing the attachment of radionuclides to the surface can be formed, and have completed the present invention.

That is, the present invention includes the following inventions.
(1) Iron (II) ions are adsorbed on the surface of a metal member constituting a nuclear power plant, and the adsorbed iron (II) ions are oxidized under a temperature condition of 20 ° C. to 200 ° C. on the surface of the metal member. Nuclear plant component with a ferrite coating.
(2) a first agent containing the iron (II) ion, a second agent for oxidizing the iron (II) ion to iron (III) ion, and a third agent for adjusting pH. A treatment liquid produced by mixing and containing the iron (II) ions and the second chemical and adjusted to a pH of 5.5 to 9.0 is brought into contact with the surface of the metal member constituting the nuclear power plant, and 20 The nuclear power plant constituent member according to (1) above, wherein a ferrite film is formed on the surface of the metal member at a temperature of from 200C to 200C.
(3) As the treatment solution, a treatment solution obtained by mixing the first agent, the second agent, and the third agent in this order and having a pH adjusted to 5.5 to 9.0 is used. A nuclear plant component according to (2) above.

ADVANTAGE OF THE INVENTION According to this invention, the method which can suppress effectively attachment of a radionuclide to a nuclear power plant structural member, the nuclear power plant structural member for that, and a ferrite film-forming apparatus are provided.

In this specification, “a metal member constituting a nuclear power plant” refers to any metal member through which reactor water containing a radioactive material generated in a nuclear reactor such as a nuclear power plant flows and contacts. As such a thing, although the metal member which comprises the reactor water recirculation system or reactor water purification system of a BWR plant is mentioned, for example, it is not restricted to this. In addition, the method of the present invention is not limited to a BWR plant, but can also be applied to metal components that come into contact with reactor water in a pressurized water (PWR) nuclear power plant. Stainless steel is mainly used for these metal members.

In the present specification, “normal temperature” and “normal pressure” mean 20 ° C. and 1 atmosphere, respectively.

In the method of the present invention, iron (II) ions are adsorbed on the surface of a metal member constituting a nuclear power plant, and the adsorbed iron (II) ions are oxidized at room temperature to 200 ° C. (preferably 60 ° C. to 100 ° C.). And forming a ferrite film on the surface of the metal member.

The method of the present invention typically comprises a first agent comprising iron (II) ions, a second agent for oxidizing said iron (II) ions to iron (III) ions, and a pH of 5 A treatment liquid mixed with a third chemical for adjusting to .5 to 9.0 is brought into contact with the surface of the metal member constituting the nuclear power plant,
It is carried out by forming a ferrite film on the surface of the metal member at room temperature to 200 ° C. (preferably 60 ° C. to 100 ° C.). Preferably, as the treatment liquid, a first agent containing iron (II) ions, a second agent for oxidizing the iron (II) ions to iron (III) ions, and pH 5.5 to 9. What is obtained by mixing the third drug for adjusting to 0 in this order is used.
The first drug containing iron (II) ions is not particularly limited as long as it is a compound containing iron (II) ions or an aqueous solution thereof. For example, iron and organic acid or inorganic acid An aqueous solution of the salt can be used. In particular, organic acids and carbonic acid are preferable because they can be decomposed into carbon dioxide and water after use. Examples of the organic acid include formic acid, malonic acid, diglycolic acid, oxalic acid and the like. From the viewpoint of the amount of ferrite film formed and the uniformity, it is preferable to use an aqueous solution of iron (II) formate as the first agent. FIG. 3 shows the relative amount of each ferrite film formed when iron (II) formate and iron (II) diglycolate are used.

Alternatively, an aqueous solution containing iron (II) ions eluted from the iron electrode by electrolysis using metallic iron as the electrode can also be used as the first agent.
As the second drug , an oxidizing agent having an action of oxidizing the iron (II) ion to iron (III) ion or an aqueous solution thereof can be used.

In order to form ferrite from a solution containing iron (II) ions, it is first necessary to oxidize a part thereof to form iron (III) ions. Examples of the oxidizing agent include hydrogen peroxide.

When iron (II) ions are oxidized to iron (III) ions, if too much iron (III) ions are formed, ferrite is not formed and iron hydroxide (Fe (OH) ₃ ) precipitates. It is preferable to use an oxidizing agent in such an amount that iron hydroxide does not precipitate. Therefore, the relationship between the ratio of oxidant concentration / iron (II) ion concentration and the amount of ferrite film formed was investigated. The result is shown in FIG. From this result, it is understood that when the ratio of the oxidizing agent (hydrogen peroxide) concentration to the iron (II) ion concentration exceeds 1/4, the ferrite film is hardly formed. 4 (0
. 25) or less, more preferably 0.15 or less.
Third Drug In the method of the present invention, a treatment liquid (preferably an aqueous solution) containing the first drug and the second drug is used, and this treatment liquid is used by adjusting the pH within a predetermined range. preferable. Therefore, in the present invention, a pH adjuster or an aqueous solution thereof is used as the third drug. The pH of the treatment liquid is adjusted to 5.5 to 9.0 with the pH adjuster. It does not specifically limit as a pH adjuster used by this invention, For example, organic bases, such as a hydrazine, can be used.
Formation of Ferrite Film on Metal Component Surface The ferrite film is formed on the surface of the metal component of the nuclear power plant using the first, second and third agents.

The first, second, and third chemicals may be brought into contact with the metal component separately, or may be used as a mixed liquid (treatment liquid) containing the first, second, and third chemicals.

When the first, second, and third chemicals are mixed and used as a processing solution, ferrite particles start to form in the solution as soon as they are mixed, so the processing solution is prepared immediately before processing the metal component. It is preferable to be (mixed).

The present inventors have also found that the ease of forming the ferrite film and the density of the formed ferrite film change depending on the order in which the first, second and third agents are mixed. According to the experiments of the present inventors, when a treatment liquid in which the first drug, the second drug, and the third drug are mixed in this order is used, the formation of the ferrite film is good (FIG. 4), It was found that a uniform and dense ferrite film was formed. In particular, it is preferable to add and mix the third chemical agent that is a pH adjuster in the reactor containment vessel.

In addition, it is preferable that the first chemical and the treatment liquid be used to remove oxygen in the aqueous solution by bubbling an inert gas such as nitrogen or argon.

The method of the present invention is for example:
a) a surge tank for storing the circulating processing liquid;
b) a circulation pump for sucking the processing liquid stored in the surge tank;
c) a first chemical tank for storing a first drug containing iron (II) ions;
d) a second chemical tank for storing a second chemical for oxidizing the iron (II) ions to iron (III) ions;
e) a third chemical tank for storing a third chemical for adjusting the pH to 5.5-9.0;
f) The chemicals from the first chemical liquid tank, the second chemical liquid tank, and the third chemical liquid tank are mixed with the processing liquid sucked by the circulation pump, and this processing liquid is supplied to the piping system to be formed. Supply piping for; and
g) a return pipe for returning the treatment liquid returned from the piping system to be deposited to the surge tank;
h) heating means for heating the temperature of the treatment liquid to 60 ° C to 100 ° C;
It can implement using the film-forming apparatus provided with these. Here, preferably, the injection position of the third medicine is installed in the reactor containment vessel.

The first drug (iron (II) ion), the second drug (oxidizing agent), and the third drug (pH adjusting agent) are injected into the circulation system in this order from the upstream side of the flow. It is preferable to set the injection position, and in particular to inject the third medicine immediately before the site to be processed. By disposing the injection position in this way, it is possible to prevent a useless ferrite film from being formed other than the processing target portion.

The processing liquid from the film forming apparatus is supplied to a metal member that is to form a ferrite film through a supply pipe.

When the metal member to be treated is divided into two systems of pipes, ferrite is applied to the surface of the metal members of both systems by alternately filling and draining the treatment liquid between the two systems. A film can also be formed.

If there is particulate matter floating such as fine solids in the treatment liquid, film formation also occurs on the surface of the particulate material during the film formation process of the ferrite film, thereby using wasteful chemicals. In order to prevent this, it is preferable to install a filter for removing particulate matter from the treatment liquid in the circulation path of the treatment liquid.

Since the surface of the metal member may have an oxide film that incorporates radionuclides generated by the operation of the reactor, before the ferrite film is formed on the surface of the metal member, contaminants such as the oxide film Is preferably removed. Examples of the method (decontamination treatment) for removing the contaminated oxide film include chemical decontamination in which the metal member surface is treated with an oxidizing agent and a reducing agent in addition to mechanical treatment such as polishing. Further, in a place where a free liquid level exists in the flow path of the processing liquid (that is, a place where a gas phase exists), the gas phase may be purged with an inert gas such as nitrogen and argon in order to prevent oxidation of the processing liquid. preferable. After the decontamination process, the ferrite film is formed before the nuclear power plant is started.

After the formation of the ferrite film, it is preferable that a part or all of the used chemicals is decomposed into a gas (at room temperature and normal pressure) and / or water, and then the ferrite film is formed again as described above. It is particularly preferred to carry out the treatment.

Specific examples of the present invention will be described below with reference to examples and drawings, but the present invention is not limited to these examples.
(Example 1)
FIG. 6 shows an overall system configuration diagram when the film forming apparatus of the present invention is connected to the recirculation pipe of the nuclear power plant, and FIG. 7 shows a detailed system configuration diagram of the film forming apparatus.

FIG. 6 shows a case where the film forming apparatus 30 of the present invention is applied to a reactor water recirculation system. As shown in FIG. 6, the nuclear power plant includes a nuclear reactor 1 in which fuel rods are accommodated in a pressure vessel, a main steam pipe 2 connected to the nuclear reactor 1, and a steam turbine connected to the main steam pipe 2. The generator 3 and the condenser 4 connected to the steam outlet of the steam turbine generator 3 are provided. Condenser 4
The condensate condensed in the above is drawn out by the condensate pump 5, and is provided with a condensate purification device 6, a feed water pump 7, a low pressure feed water heater 8, and a high pressure feed water heater 9. 10 is returned to the reactor 1 as feed water. The heat sources of the low-pressure feed water heater 8 and the high-pressure feed water heater 9 are covered by the extraction of the steam turbine generator 3.

In addition, a plurality of reactor water recirculation systems for circulating the cooling water in the reactor 1 are provided, and the reactor water extracted by the plurality of recirculation pumps 21 connected to the bottom of the reactor 1 is supplied to the reactor water recirculation piping. It is configured to circulate back to the upper part of the nuclear reactor 1 through 22. The reactor water purification system for purifying the reactor water of the nuclear reactor 1 uses the regenerative heat exchanger 25 and the non-regenerative heat exchanger for the reactor water extracted by the purification system pump 24 connected to the reactor water recirculation pipe 22. 26, the cooled reactor water is purified by the reactor water purification device 27, the purified reactor water is heated by the regenerative heat exchanger 25, and then the downstream side of the high-pressure feed water heater 9 of the feed water system To return to the reactor 1.

The film forming apparatus 30 can be connected to the nuclear reactor 1 as follows. The operation of the nuclear reactor 1 is stopped, the bonnet of the valve 23 of the reactor water purification system pipe branched from the reactor water recirculation pipe 22 is opened, and the reactor water purification apparatus 27 side is closed. And the temporary piping connected with the film-forming apparatus is connected to the upstream of the recirculation pump 21 of the reactor water recirculation piping 22 via the flange of the valve 23.
A temporary pipe connected to the other side of the film forming apparatus 30 is connected to the downstream side of the recirculation pump 21.
That is, a part of the reactor water from the reactor water recirculation pipe 22 passes through the film forming apparatus, and again the reactor water recirculation pipe 2
Connect each device and piping so as to return to 2.

An example of the film forming apparatus 30 is shown in FIG. The film forming apparatus 30 of the present embodiment is configured to be used for chemical decontamination processing. The surge tank 31 filled with water (treatment liquid) used for the ferrite film treatment includes a circulation pump 32 and a valve 3.
3 and 34 etc. are connected to one end of the reactor water recirculation pipe 22.

Chemical liquid tanks 45 and 46 are connected to the processing liquid pipe 35 via valves 41 and 42 and injection pumps 43 and 44. The upstream chemical solution tank 45 stores a first drug (iron (II) ions: for example, an aqueous solution containing divalent iron (II) ions prepared by dissolving iron with formic acid). A second chemical (oxidant: for example, hydrogen peroxide solution) is stored in the chemical tank 46 on the downstream side. A chemical liquid tank 40 that stores a third chemical (pH adjusting agent: for example, hydrazine) is connected to the processing liquid pipe 35 on the downstream side of the chemical liquid tank 46.

A flow path returning to the surge tank 31 via the valve 36 and the ejector 37 is provided, and the ejector 3
7 may be configured so that chemicals for chemically decontaminating the contaminants in the pipe (for example, permanganic acid for oxidizing and dissolving, oxalic acid for reducing and dissolving) can be input.

The processing liquid supplied to one end of the reactor water recirculation pipe 22 by the circulation pump 32 passes through the reactor water recirculation pipe 22, passes through the valve 47 from the other end, and returns to the film forming apparatus 30 again. The processing liquid returned through the valve 47 is carried to the surge tank 31 through the circulation pump 48, the valve 49, the heater 53 and the valves 55, 56, 57.

A valve 50 and a filter 51 are connected to the valve 49 in parallel. The filter 51 is for capturing particulate matter floating in the processing liquid. When forming the ferrite film, it is preferable to open the valve 50 so that the filter 51 can pass water.

  A cooler 58 and a valve 59 are connected in parallel to the heater 53 and the valve 55.

The valve 56 includes a cation exchange resin tower 60 via a valve 61 and a mixed bed resin tower 6.
2 are connected in parallel with each other through a valve 63.

A decomposition device 64 is connected to the valve 57 in parallel via a valve 65. The decomposition device 64 is connected to the discharge side of the injection pump 44 connected to the chemical liquid tank 46 through the valve 54 so that the hydrogen peroxide solution stored in the chemical liquid tank 46 can be injected into the decomposition device 64. Has been. When an organic acid or carbonic acid is used as a counter anion of iron (II) ions in the first drug, or when a compound such as hydrazine is used as a pH adjuster in the third drug, these are decomposed by the decomposition device 64. It can be decomposed into water or a substance that is a gas at normal temperature and pressure. By decomposing part or all of the first drug and the third drug into water, carbon dioxide, or releasable gas by the decomposition device 64, the amount of waste can be reduced. In order to reduce the amount of drug used, it is preferable to separate and recover the drug that has not reacted from the treatment liquid and reuse it.

In this example, the oxidizer necessary for ferrite film formation and the oxidizer necessary for decomposition are the same hydrogen peroxide, so the equipment is reduced by sharing the chemical tank and injection pump. If the connecting pipe becomes long, it can be installed separately.

The position of the valve 42 for injecting the second agent (oxidizing agent) is downstream of the valve 41 for injecting the first agent (iron (II) ions), and the third agent (pH adjusting agent) is injected. Valve 38 to inject
The position of the valve 38 for injecting the third chemical is set on the downstream side of the valve 42 for injecting the oxidant and as close as possible to the site to be processed (preferably, the reactor containment vessel It is preferable to set to (inside).

Furthermore, it is preferable to bubble an inert gas such as nitrogen or argon in the chemical tank 45 and the surge tank 31 in order to remove oxygen in the aqueous solution.

Next, a radionuclide adhesion suppression method using the film forming apparatus 30 of the present invention will be described with reference to the flowchart shown in FIG.
Step S1 (Installation of film forming apparatus)
In carrying out the method of the present invention, the film forming apparatus 30 is connected to a piping system including constituent members to be processed. For example, as shown in FIG. 8, when the metal member of the reactor water recirculation system is to be treated, the connection between the reactor 1 and the reactor water recirculation pipe 22 is connected to the plug 28 when the reactor 1 is stopped. The film forming apparatus 30 is connected through the valves 12 and 13 which are separated from each other and branched from the reactor water recirculation pipe 22. Here, in FIG. 8, a part of the detailed film forming apparatus 30 shown in FIG. 7 is omitted.
Process S2 (decontamination process)
Next, in the case of the present embodiment, contaminants such as an oxide film that incorporates a radionuclide formed on the surface of the metal member in contact with the reactor water are decontaminated by chemical treatment using the film forming apparatus 30. . In carrying out the method of suppressing radionuclide adhesion according to the present invention, it is preferable to carry out chemical decontamination, but the surface of the metal member that is the subject of the ferrite film treatment is exposed without the presence of a contaminated oxide film. If you do not have to. Further, instead of chemical decontamination, mechanical decontamination treatment such as polishing may be performed.

Chemical decontamination is a well-known method and can be performed, for example, as follows. Valve 3
3, 34, 47, 49, 55, 56, 57 are opened and the other valves are closed, the circulation pump 32 and the circulation pump 48 are started, and the inside of the reactor water recirculation system 22 subject to chemical decontamination The processing liquid in the surge tank 31 is circulated. And the temperature of a process liquid is heated up to about 90 degreeC with the heater 53. FIG. Next, the valve 36 is opened, and a necessary amount of an oxidizing agent (for example, potassium permanganate) and / or a reducing agent (for example, oxalic acid) is injected into the surge tank 31 from a hopper installed in the ejector 37. Next, the solution in the surge tank 31 is allowed to flow to the site to be decontaminated, and contaminants such as a contaminated oxide film formed can be removed by oxidation dissolution and / or reduction dissolution. Specifically, after oxidizing and dissolving the contaminants by flowing potassium permanganate, oxalic acid is similarly injected from the hopper into the surge tank 31 in order to decompose the permanganate ions remaining in the treatment liquid. At this time, the following reaction occurs:
2KMnO ₄ + 5C ₂ O ₄ H ₂ + 6H ⁺ → 2K ⁺ + 2Mn ²⁺ + 10CO ₂ + 8H ₂ O
Subsequently, in order to reduce and dissolve contaminants, oxalic acid is further injected into the treatment liquid, and in order to adjust the pH of the treatment liquid, the valve 38 is opened to treat the pH adjuster (for example, hydrazine) from the chemical liquid tank 40. Inject into liquid. The metal cations eluted in the treatment liquid by this series of treatments are removed from the treatment liquid through the cation exchange resin tower 60.

After the chemical decontamination, a part of the treatment liquid is passed through the decomposition device 64 in order to decompose oxalic acid in the treatment liquid. At this time, the valve 54 is opened, and the second chemical (oxidant: for example, hydrogen peroxide solution) in the chemical tank 46 is simultaneously allowed to flow into the decomposition device 64 to convert oxalic acid and hydrazine based on the following chemical reaction formula. Disassemble:
(COOH) ₂ + H ₂ O ₂ → 2CO ₂ + 2H ₂ O
N ₂ H ₄ + 2H ₂ O ₂ → N ₂ + 4H ₂ O
After decomposing oxalic acid and hydrazine, the heater 53 is used to remove impurities in the treatment liquid.
Is turned off and the valve 55 is closed. At the same time, the valve 59 of the cooler 58 is opened and the processing liquid is passed through the cooler 58 to lower the temperature of the processing liquid. As a result, the temperature of the treatment liquid is lowered to a temperature at which water can be passed through the mixed bed resin tower 62 (for example, 60 ° C.), then the valve 61 of the cation resin tower 60 is closed and the valve 63 on the mixed bed resin tower 62 side is opened. Then, the processing liquid is passed through the mixed bed resin tower 62 to remove impurities in the processing liquid.

These series of steps, that is, temperature increase, oxidative dissolution of contaminants, decomposition of oxidant, reductive dissolution of contaminants, decomposition of reducing agent, and purification operation (removal of contaminants and impurities) are repeated about 2 to 3 times. Thus, the contaminants including the contaminated oxide film deposited on the surface of the metal member can be dissolved and removed. And it is preferable to perform a decontamination process to the level which the density | concentration of the decontamination agent of a decontamination liquid, a metal ion, etc. can accept in a radioactive substance handling facility by the last purification operation.
Process S3 (heating of processing liquid)
After completion of the decontamination process, the treatment liquid is heated. The valve 49 is closed and the valve 50 is opened to start water flow to the filter 51. In order to prevent this, if fine solids remain in the treatment liquid, film formation occurs on the surface of the solids during the formation of the ferrite film, and useless chemicals are used. A filter 51 is used. In addition, when water is passed through the filter 51 during the step S2, it is not appropriate because solid matter containing high radioactivity is captured and the dose rate of the filter may become too high.

The processing liquid is heated to a predetermined temperature by the heater 53 (from room temperature to 200 ° C, preferably from 60 ° C to 100 ° C).
Adjust to. Water flow to the mixed bed resin tower 62 is stopped by opening the valve 56 and closing the valve 63. The temperature of the treatment liquid at this time is not particularly limited as long as it is a temperature at which a dense ferrite film is formed to such an extent that the radionuclide is not taken in, but is preferably 200 ° C. or lower. The lower limit may be normal temperature, but 60 ° C. or higher is preferable in consideration of the formation rate of the ferrite film. Further, although the method of the present invention can be carried out even at a temperature exceeding 100 ° C., the system must be pressurized in order to suppress the boiling of the processing liquid, and the pressure resistance of the apparatus is required, and the equipment cost is increased. Is increased at a temperature of 100 ° C. or lower.
Step S4 (Addition of the first chemical (iron (II) ion) to the treatment liquid)
In order to form a ferrite film, iron (II) ions must be adsorbed on the surface of the film formation target part. Iron (II) ions in this solution are oxidized by dissolved oxygen to iron (III) ions according to the following formula, and the generated iron (III) ions are precipitated as iron hydroxide according to the following formula.
4Fe ²⁺ + O ₂ + 2H ₂ O → 4Fe ³⁺ + 4OH ⁻ Fe ³⁺ + 3OH ⁻ → Fe (OH) ₃
However, since this iron hydroxide does not contribute to the formation of the ferrite film, it is preferable to remove the dissolved oxygen in the first chemical solution and the treatment solution as much as possible so that these reactions do not occur. Examples of the method for removing dissolved oxygen in the solution include bubbling with an inert gas such as nitrogen gas and argon gas, vacuum deaeration, and the like.

When the temperature of the circulated processing liquid reaches a predetermined temperature, the valve 41 is opened and iron is added from the chemical tank 45 to the first chemical (for example, formic acid containing iron (II) ions) into the processing liquid.
Step S5 (Addition of second chemical (oxidizing agent) to treatment liquid)
Subsequently, to ferritize iron (II) ions adsorbed on the surface of the metal member to be treated,
The valve 42 is opened and an oxidizing agent (for example, hydrogen peroxide solution) stored in the chemical tank 46 is added to the processing liquid.
Step S6 (Addition of third drug (pH adjuster) to treatment liquid)
Finally, in order to adjust the pH of the treatment liquid to 5.5 to 9.0, the valve 38 is opened and a pH adjuster (for example, hydrazine) is added from the chemical tank 40 into the treatment liquid. First, second and third
A treatment liquid to which all of the chemicals are added is brought into contact with the site to be treated to form a ferrite film (for example, a magnetite film).

Steps S4, 5, and 6 are continuously performed, that is, the injection of the second drug is started at the same time when the first drug reaches the second drug injection point, and the first drug and the second drug are added. It is preferable that injection of the third drug is started at the same time that the treated liquid reaches the third drug injection point.
If only the first drug is injected first and the system is circulated, there is a high possibility that an oxidation reaction will occur due to the dissolved oxygen remaining in the system, leading to loss of the drug due to a useless reaction and inhibition of the reaction. For this reason, not only the bubbling of the chemical tank 45 and the surge tank 31 but also the gas phase of the recirculation pipe 22 in which the free liquid level is generated is an inert gas (for example, nitrogen) connected to the plugs 28 and 29 as shown in FIG. It is desirable to purge with an inert gas using a gas) supply line and a vent line.

When the second drug is supplied to the first drug, an oxidation reaction of iron (II) ions is started. At this time, the ratio of the concentration of the oxidizing agent (for example, hydrogen peroxide) in the second drug to the concentration of iron (II) ions in the first drug is not more than 1/4 (0.25), preferably 0. .15 or less, iron (II)
The abundance ratio of ions and iron (III) ions is a suitable condition for the film formation reaction. However, as it is, the treatment liquid is acidic and a ferrite film cannot be formed. Therefore, it is necessary to add a pH adjuster to the treatment liquid to adjust the pH of the treatment liquid to near neutrality. Since the ferrite film formation reaction starts simultaneously with the addition of the pH adjusting agent, the injection point of the third agent (pH adjusting agent) is as shown in FIG. 8 in order to prevent useless film formation outside the target site. ,
It is preferable to install the storage container 11 just before (upstream side) the processing object inside.

The order of addition of the first, second and third drugs is preferably added in the order of the first, second and third drugs. Although it may be added in the order of the second, first, and third chemicals, hydrogen peroxide is not preferable because it easily decomposes on the metal surface having a high temperature and is partially consumed if injected first. In the case of the addition order of the first, third and second chemicals, the formation of the ferrite film is recognized, but the size of the particles forming the ferrite film increases. Therefore, in order to efficiently use the drug and form a denser ferrite film, it is desirable to add them in the order of the first, second and third drugs.

In the case shown in FIG. 8, free liquid levels are generated at two locations of the recirculation pipe 22. The liquid level of the processing liquid needs to be controlled so that the processing liquid does not enter the pressure vessel 1, but it is desirable that the water level be as high as possible in order to keep the dose rate in the dry well low. The height of these liquid levels can be controlled by finely adjusting the flow rate balance of the circulation pumps 32 and 48 using the valves 33 and 49 (FIG. 7). A ferrite film is easily formed in the vicinity of the gas-liquid interface, and the ferrite film can also be efficiently formed on the riser pipe located above the recirculation pipe 22 by changing the liquid level.
Process S7 (Confirmation of ferrite film formation)
Thus, when it is recognized that the formation of the ferrite film is sufficient, the process proceeds to the next step S8 (waste liquid treatment).

When it is recognized that the formation of the ferrite film is incomplete or insufficient, the process returns to step S4, and the first, second, and third chemicals are added to the treatment liquid as necessary, and the target thickness is reached. The ferrite film formation operation is repeated until the ferrite film is formed.
Process S8 (waste liquid treatment)
Since substances such as formic acid used in the first chemical and hydrazine used in the third chemical remain in the processing liquid after the ferrite film is formed, the waste liquid treatment in step S8 is performed before discarding the processing liquid. It is preferable to decompose and remove them by performing the above. Although these substances can be processed by the ion exchange resin tower 60, waste of the ion exchange resin is increased, so that these substances are preferably decomposed by the decomposition apparatus 64. By this decomposition treatment, formic acid is decomposed into carbon dioxide and water according to the following formula, and hydrazine is decomposed into nitrogen and water.
HCOOH + H ₂ O ₂ → CO ₂ + 2H ₂ O
N ₂ H ₄ + 2H ₂ O ₂ → N ₂ + 4H ₂ O
Thereby, the load of the ion exchange resin tower | column 60 can be reduced and the waste amount of an ion exchange resin can be reduced. In the decomposition treatment, as in the decomposition of oxalic acid, hydrogen peroxide is introduced into the treatment liquid flowing into the decomposition apparatus 64 to decompose formic acid and hydrazine.

In this manner, a dense ferrite film can be formed at the target site to suppress the attachment of radionuclides (for example, radioactive cobalt ions) to the target site during normal reactor operation. As a result, it is possible to reduce the dose rate of the piping of the reactor water recirculation system and reduce the exposure of the inspection worker during the regular inspection work. In addition, the amount of radioactive waste accumulated in the ion exchange resin can be reduced. Furthermore, since the method of the present invention does not use chemicals such as chlorine for forming the ferrite film, the soundness of the nuclear reactor components is not impaired.
(Example 2)
FIG. 10 shows a system configuration diagram in the case of having two recirculation system pipes 22.

The film forming apparatus 30 is basically the same as that shown in FIGS. 8 and 7, but a valve for switching the flow path is added so that the processing liquid can flow through both of the recirculation pipes 22. Is different.

The basic work flow for chemical decontamination and ferrite film generation is the same as that shown in Fig. 1, but recirculation of two systems (hereinafter, one is called "A system" and the other is "B system") Piping 2
2 to treat the ferrite film at once, the treatment liquid is changed from the A system to the B system as shown below.
Next, it differs in that it flows so as to be alternately transferred from the B system to the A system.

In the apparatus of Example 1 (FIG. 8), the film forming apparatus and the recirculation pipe 22 are connected by two pipes, whereas in the apparatus of Example 2 (FIG. 10), the film forming apparatus and Each of the A system and the B system recirculation pipes 22 is connected by one pipe. Recirculation piping 2 if drainage is considered
It is preferable to connect a pipe from the film forming apparatus to the lowest position of 2. Along with this, two points for injecting the third drug (pH adjusting agent) are also required immediately before the respective recirculation pipes 22, so atoms from the third chemical tank storing the pH adjusting agent are required. Containment vessel 11
Two injection lines are also required, and the valve is configured to select an injection line with a valve.

As a specific operation procedure, for example, first, water (treatment liquid) is injected into the system A (22a) and the film forming apparatus 30 so as to obtain a liquid level necessary for decontamination. Next, valves 77 and 78 are opened,
If the circulation pumps 32 and 48 are started with the valves 76 and 79 closed, the water retained in the A system is transferred to the B system (22b). Heating is performed by the heater 53 while transferring the treatment liquid. When all the water in system A has been transferred to system B, valves 77 and 78 are closed, and valve 76,
When 79 is opened, water is transferred from the B system to the A system in the future. When forming the ferrite film, the opening and closing of the valves 38a and 38b is controlled so that the third chemical (pH adjusting agent) is injected into the system on the side of injecting the treatment liquid.

Except for operating the valve to control the flow of the processing liquid, chemical decontamination and generation of a ferrite film can be performed in the same procedure as in Example 1.

By such an operation, it is possible to simultaneously form the ferrite film of the two recirculation pipes 22. Valve switching is preferably automated.

In this method, since the liquid level inside the recirculation pipe 22 moves due to the injection / discharge of the processing liquid into the recirculation pipe 22, many parts of the inner surface of the pipe have time to become a gas-liquid interface. Film formation tends to be uniform. In addition, since the system satisfies a certain liquid volume, the risk that the maximum liquid level exceeds the set upper limit value is reduced, and the possibility that treated water will flow into the nuclear reactor due to an operational error is reduced.
(Example 3)
FIG. 11 shows a system configuration diagram of the third embodiment. Compared with the embodiment of Example 1 (FIG. 7), the embodiment of Example 3 has the same basic arrangement of devices and piping, but the surge tank 31 and the first
This is different in that an inert gas (for example, nitrogen) bubbling device 71 is installed in the chemical liquid tank 45 of the chemical.

By bubbling the first chemical and the treatment liquid in the surge tank with an inert gas, the dissolved oxygen in each solution can be removed to make a solution substantially free of oxygen. As a result, it is possible to suppress the formation of iron (III) ions in the solution that do not contribute to the formation of the ferrite film and promote the formation reaction of the ferrite film.
Example 4
In FIG. 12, the system configuration | structure figure of Example 4 is shown. The embodiment of Example 4 is the same as the embodiment of Example 1 (FIG. 7) in the basic arrangement of the apparatus and piping, but the first chemical liquid tank 4
5, an electrolytic cell 81 is installed, and is different in that iron (II) ions dissolved from the iron plate 82 (metal iron electrode) are used by electricity supplied from the DC power supply 83 in the electrolytic cell 81. Iron (I
I) The treatment liquid containing ions is guided to the treatment liquid pipe 35 through the filter 51 by the injection pump 43.

In addition, during electrolysis, carbon dioxide gas is preferably bubbled from the carbon dioxide gas supply device 84 to the electrolytic cell 81 and supplied in order to increase the electric conductivity of the water so that the electrolytic current can easily flow.

Since metal fine particles are generated when the polarity of electrolysis is changed, the filter 51 is preferably installed on the outlet side of the electrolytic cell 81 in order to remove it.

The merit of constructing such a system is that, since the solubility of iron (II) ions is low, a large chemical tank 45 is usually required. However, in the method of this embodiment, iron (II) ions are efficiently used in a compact electrolytic cell. In addition, since carbon dioxide gas is used, waste disposal is simplified.
(Example 5)
In FIG. 13, the system configuration | structure figure of Example 5 is shown. Compared with the embodiment of Example 1 (FIG. 7), the embodiment of Example 5 has the same basic arrangement of the apparatus and piping, but a branch is provided on the downstream side of the filter 51, and iron ( II) Chromatogram for ion concentration measurement is connected to iron (I
I) It differs in that it is configured so that the ion concentration can be measured.

FIG. 14 is a graph showing the relationship between the elapsed time after mixing each drug, the iron (II) ion concentration, and the coating amount. The ferrite film growth is saturated about 2 hours after mixing the chemicals, and the iron (II) at that time is saturated.
It can be seen that the ion concentration is about 1/6 of the initial concentration. From this, the degree of formation of the ferrite film can be estimated from the iron (II) ion concentration.

The iron (II) ion concentration measurement chromatogram in FIG. 13 may be replaced with a platinum electrode potential measurement device. FIG. 15 is a graph showing the relationship between the elapsed time after mixing each chemical, the platinum electrode potential of the treatment liquid, and the coating amount. About 2 hours after mixing the chemicals, the growth of the ferrite film was saturated, and the platinum electrode potential at that time was about -400 mV. From this, the degree of formation of the ferrite film can be estimated from the platinum electrode potential.
(Example 6)
FIG. 16 is a flowchart showing the procedure of the sixth embodiment. In Example 1, when the formation of the ferrite film was insufficient, each agent was further added to the treatment liquid and the ferrite film formation treatment was repeated. In Example 6, the same treatment liquid was not used and a new one was used. It is different in that the ferrite film is formed by exchanging with a different treatment solution.

In this method, the formation efficiency of the ferrite film is excellent. FIG. 17 shows Example 1 and Example 6.
The result of the comparison experiment with the case of is shown. In the case where the ferrite film formation treatment was repeated, it was shown that the method of Example 6 was superior in formation efficiency of the ferrite film.

Commercially, the amount of the reaction solution is large and difficult to replace, but the same effect can be obtained by using a treatment solution obtained by re-adding each chemical in the treatment solution obtained by decomposing formic acid and hydrazine by the decomposition device 64. be able to.

It is a flowchart which shows one Embodiment of the attachment suppression method of the radionuclide of this invention. It is a figure which shows the adhesion amount (relative value) of Co-60 when the stainless steel by which the surface was processed by various methods was immersed in the high temperature water of BWR service operation conditions. It is the figure which showed the relationship between various organic acid iron (II) and a ferrite film production amount (relative value). It is the figure which showed the relationship between the addition order of a chemical | medical agent, and the ferrite film production amount (relative value). It is a figure which shows the relationship between hydrogen peroxide / iron (molar ratio) and the amount of ferrite film production | generation (relative value). 1 is an overall system configuration diagram according to an embodiment of Example 1. FIG. 1 is a detailed system configuration diagram of a film forming apparatus according to an embodiment of Example 1. FIG. In embodiment of Example 1, it is the figure which showed the structure at the time of setting the injection | pouring point of the 3rd chemical | medical agent in the reactor containment vessel. In embodiment of Example 1, it is the figure which showed the structure at the time of carrying out nitrogen purge of the gaseous phase of recirculation piping upper part. FIG. 6 is an overall system configuration diagram according to an embodiment of Example 2; 6 is a diagram illustrating a configuration of a film forming apparatus according to an embodiment of Example 3. FIG. 6 is a diagram showing a configuration of a film forming apparatus according to an embodiment of Example 4. FIG. 6 is a diagram illustrating a configuration of a film forming apparatus according to an embodiment of Example 5. FIG. It is a figure which shows the relationship between the ferrite film formation amount (relative value) and the iron (II) ion concentration (relative value) in a process liquid. It is a figure which shows the relationship between the ferrite film formation amount (relative value) and the platinum electrode potential of a process liquid. It is a flowchart which shows another one Embodiment of the adhesion suppression method of the radionuclide of this invention. It is the figure which compared the ferrite film production amount (relative value) with the method of adding a reagent to a process liquid, and the method of replacing | exchanging a process liquid.

Explanation of symbols

DESCRIPTION OF SYMBOLS 1 ... Reactor pressure vessel 2 ... Main steam pipe 3 ... Turbine 4 ... Condenser 5 ... Condensate pump 6 ... Condensate purification apparatus 7 ... Feed water pump 8, DESCRIPTION OF SYMBOLS 9 ... Feed water heater 10 ... Feed water piping 11 ... Reactor containment vessel 21 ... Recirculation pump 22 ... Recirculation piping 28, 29 ... Plug 30 ... Film-forming device 31 ... Surge tanks 32, 48 ... Circulation pump 35 ... Treatment liquid pipe 37 ... Ejectors 39, 43, 44 ... Injection pumps 40, 45, 46 ... Chemical liquid tank 51 ... Filter 53 ... Heater 58 ... Cooler 60 ... Cation exchange resin tower 62 ... Mixed bed resin tower 64 ... Decomposition device 81 ... Electrolyzer 82 ... Iron plate 83 ... DC Power source 84 ... Carbon dioxide supply device 86 ... Ion chromatogram for measuring iron (II) ion concentration

Claims (3)

  An iron (II) ion is adsorbed on the surface of a metal member constituting a nuclear power plant, and the adsorbed iron (II) ion is oxidized under a temperature condition of 20 ° C. to 200 ° C. to form a ferrite film on the surface of the metal member. Formed nuclear plant components.   Produced by mixing a first agent containing the iron (II) ion, a second agent for oxidizing the iron (II) ion to iron (III) ion, and a third agent for adjusting pH Then, the treatment liquid containing the iron (II) ion and the second chemical agent and adjusted to pH 5.5 to 9.0 is brought into contact with the surface of the metal member constituting the nuclear power plant, and the temperature is 20 ° C. to 200 ° C. The nuclear plant component according to claim 1, wherein a ferrite film is formed on the surface of the metal member at ° C.   The treatment liquid obtained by mixing the first drug, the second drug, and the third drug in this order and having a pH adjusted to 5.5 to 9.0 is used as the treatment liquid. A nuclear plant component described in 1.

Images